JUNS
Price:
$1.22
Market Cap:
$42.05M
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is develo...[Read more]
Industry
Biotechnology
IPO Date
2022-01-18
Stock Exchange
NASDAQ
Ticker
JUNS
According to Jupiter Neurosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -351.97%. This represents a change of -66.79% compared to the average of -1059.89% of the last 4 quarters.
The mean historical ROE of Jupiter Neurosciences, Inc. over the last ten years is 47.21%. The current -351.97% ROE has changed -845.48% with respect to the historical average. Over the past ten years (40 quarters), JUNS's ROE was at its highest in in the December 2021 quarter at 39.62%. The ROE was at its lowest in in the September 2025 quarter at -3984.94%.
Average
47.21%
Median
65.07%
Minimum
-58.48%
Maximum
84.58%
Discovering the peaks and valleys of Jupiter Neurosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 89.69%
Maximum Annual ROE = 84.58%
Minimum Annual Increase = -170.92%
Minimum Annual ROE = -58.48%
| Year | ROE | Change |
|---|---|---|
| 2024 | -58.48% | -170.92% |
| 2023 | 82.46% | 18.83% |
| 2022 | 69.39% | -17.96% |
| 2021 | 84.58% | 89.69% |
| 2020 | 44.59% | -26.59% |
The current ROE of Jupiter Neurosciences, Inc. (JUNS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.13%
5-year avg
44.51%
10-year avg
47.21%
Jupiter Neurosciences, Inc.’s ROE is greater than Skye Bioscience, Inc. (-68.65%), less than Serina Therapeutics, Inc. (522.99%), greater than Aligos Therapeutics, Inc. (-132.42%), greater than ABVC BioPharma, Inc. (-64.70%), greater than X4 Pharmaceuticals, Inc. (-375.31%), greater than Kezar Life Sciences, Inc. (-63.52%), less than FibroGen, Inc. (0.95%), greater than Genenta Science S.p.A. (-70.71%), less than Mersana Therapeutics, Inc. (183.15%), greater than Grace Therapeutics, Inc. (-12.76%),
| Company | ROE | Market cap |
|---|---|---|
| -68.65% | $38.77M | |
| 522.99% | $37.00M | |
| -132.42% | $62.09M | |
| -64.70% | $36.66M | |
| -375.31% | $43.35M | |
| -63.52% | $45.77M | |
| 0.95% | $33.37M | |
| -70.71% | $35.60M | |
| 183.15% | $137.32M | |
| -12.76% | $46.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jupiter Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jupiter Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Jupiter Neurosciences, Inc.'s ROE?
How is the ROE calculated for Jupiter Neurosciences, Inc. (JUNS)?
What is the highest ROE for Jupiter Neurosciences, Inc. (JUNS)?
What is the 3-year average ROE for Jupiter Neurosciences, Inc. (JUNS)?
What is the 5-year average ROE for Jupiter Neurosciences, Inc. (JUNS)?
How does the current ROE for Jupiter Neurosciences, Inc. (JUNS) compare to its historical average?